Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07465185 Dexmedetomidine Hydrochloride Anesthesia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07465185 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
NCT07463183 PRA-052 Colitis, Ulcerative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07463183 clinical trial report covering PRA-052, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07465120 CMS-D001 Severe Atopic Dermatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07465120 clinical trial report covering CMS-D001, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07465276 Ficerafusp alfa Squamous Cell Carcinoma of Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07465276 clinical trial report covering Ficerafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07464756 Apatinib Mesylate Locally Advanced Gastroesophageal Junction Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07464756 clinical trial report covering Apatinib Mesylate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260918 Recombinant anti-human EGFR antibody/IL-10 bispecific FC fusion protein(Dingfu B Malignant Pleural Effusion Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
CTR20260918 clinical trial report covering Recombinant anti-human EGFR antibody/IL-10 bispecific FC fusion protein(Dingfu B, Phase 2, endpoints, sponsor, g
Latest Hotspot
8 min read
CTR20260911 Zhike Juhong Granules Pulmonary Disease, Chronic Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
CTR20260911 clinical trial report covering Zhike Juhong Granules, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07465198 Autologous Stem Cell Therapy(Biocells Medical) Multiple System Atrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07465198 clinical trial report covering Autologous Stem Cell Therapy(Biocells Medical), Phase 2, endpoints, sponsor, geography, readout timing and devel
Latest Hotspot
8 min read
ChiCTR2600120353 FNS-007 Rheumatoid Arthritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
ChiCTR2600120353 clinical trial report covering FNS-007, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600120362 Apalutamide HER2 negative Gastroesophageal Junction Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
ChiCTR2600120362 clinical trial report covering Apalutamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07463820 Epoetin Alfa Anemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07463820 clinical trial report covering Epoetin Alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07466927 Trastuzumab Rezetecan HER2-negative breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07466927 clinical trial report covering Trastuzumab Rezetecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.